Liquid biopsy in cancer treatment

SEP

Wednesday, September 16

3:00 PM - 3:30 PM

How liquid biopsy can support cancer treatment decisions and follow up care.

Dr. med. Dr. rer. nat. Sven Borchmann will explain the value that ctDNA MRD testing (liquid biopsy) can offer for treatment decisions and follow up care. Afterwards, you will have the opportunity to ask your questions directly and discuss them with Dr. Borchmann.

Speaker

Sven Borchmann

Founder & CEO @ LIQOMICS

ctDNA-based MRD diagnostics for lymphoma & solid tumors | MD, PhD | Principal Investigator @ University of Cologne

Hosted by LIQOMICS

Replays

See all

27 min

Liquid Biopsy bei der Krebstherapie

Sven Borchmann

26 min